THE JKTG Foundation had an amazing meeting a couple of weeks ago in Washington, DC with Mr. Ted Giovanis. Who founded his own cancer research foundation when his wife succumbed to breast cancer. He is an amazing man and inspiration when he turned this awful personal experience into a Foundation to find cancer cures. Great talks, great people and a great setting and I learned a lot! It was an amazingly great meeting. #MoffittNews #JKTG

A Man In Action Ted Giovanis and his foundation: The Great meeting in Washington at the annual presentations of the JKTG Foundation symposium I'm extremely grateful to have been invited and made all these wonderful leaders in the field. Ted is amazing, in all the ways one could react to the illness in your spouse. You chose to get involved with the Research funding effort which is extremely important now. As a fantastic and creative symposium with great speakers and we had a bunch new collaborations to make to see if we can Cure Breast Cancer leptomeningeal disease! #MoffittNews #JKTG

I’m headed to #SITC26! I am looking forward to sharing my research, (#506) Preclinical Evaluation of Intrathecal TRP1-Targeted CAR-T Cells Demonstrates Durable Antitumor Immunity in Melanoma Leptomeningeal Disease, with attendees at the meeting in Phoenix! @sitcancer @MoffittResearch @MoffittNews Learn more and register: sitcancer.org/2026/home@sitc…

🎉 I am proud to share that I have been selected to receive the 2026 CNS Metastases Award for my abstract, “A First in Human Phase 1 Study of Intrathecal Peptide-Pulsed Dendritic Cells for HER2+ and Triple Negative Breast Cancer Leptomeningeal Disease.” This recognition reflects the dedication of our entire research team and our commitment to advancing innovative treatment options for patients with leptomeningeal disease. I am honored that this work will be featured at the upcoming 31st Annual Meeting of the Society for Neuro-Oncology in Philadelphia. Thank you to my colleagues, collaborators, and patients who make this work possible. Looking forward to continuing our efforts to improve outcomes for patients facing these challenging diagnoses. @MoffittNews #NeuroOncology #CancerResearch #BreastCancerResearch #SNO2026 #InnovationInMedicine #BrainTumorResearch 📷

🎉 I am proud to share that I have been selected to receive the 2026 CNS Metastases Award for my abstract, “A First in Human Phase 1 Study of Intrathecal Peptide-Pulsed Dendritic Cells for HER2+ and Triple Negative Breast Cancer Leptomeningeal Disease.” This recognition reflects the dedication of our entire research team and our commitment to advancing innovative treatment options for patients with leptomeningeal disease. I am honored that this work will be featured at the upcoming 31st Annual Meeting of the Society for Neuro-Oncology in Philadelphia. Thank you to my colleagues, collaborators, and patients who make this work possible. Looking forward to continuing our efforts to improve outcomes for patients facing these challenging diagnoses. @MoffittNews #NeuroOncology #CancerResearch #BreastCancerResearch #SNO2026 #InnovationInMedicine #BrainTumorResearch 🧠🔬🏆

Honored to serve as the keynote speaker at the 23rd Annual Retreat hosted by the Brain Tumor Center of Excellence at Atrium Health Wake Forest Baptist Comprehensive Cancer Center. I enjoyed discussing innovative approaches to treating leptomeningeal disease and collaborating with colleagues dedicated to advancing neuro-oncology research and patient care. @MoffitNews @MoffittResearch #BrainTumorResearch #CancerResearch

Great dinner at the oldest restaurant in Boston for SNO/ASCO 2026. I learned alot. It always great to touch base with friends and colleagues. #MoffittNews

Help us spread the word! 📢 A new Phase II clinical trial for patients with breast cancer leptomeningeal disease (LMD) is now enrolling at @MoffittNews. The study is evaluating intrathecal cDC1s combined with intrathecal trastuzumab (HER2+) or intrathecal nivolumab (HER2-). Learn more: 🔗 Moffitt: moffitt.org/clinical-trials-… 🔗 ClinicalTrials.gov: clinicaltrials.gov/study/NCT… Please share the Facebook post to help connect patients and families with this research: 🔗 facebook.com/share/p/1EwoJ88… #ClinicalTrials #BreastCancer #LeptomeningealDisease #LMD #CancerResearch

Great talks at #ASCO26 in Neuro oncology! Here’s a brief interview highlighting our work. Watch the videos here: Peter Forsyth interviews @NewsMoffitt @VJOncology Here is the link to the videos from my interview: vjoncology.com/?s=Peter+Fors….

I’m grateful to @BN9 for sharing Heather’s incredible story. Heather is a true hero—a courageous warrior whose strength, resilience, and determination inspire us all. Stories like hers are only possible because of groundbreaking discoveries and the generosity of collaborators like Dr. Brian Czerniecki. His scientific leadership, collaboration, and unwavering support continue to move the field forward. Thank you, Brian, for helping make hope a reality for patients and families. @MoffittNews Bay News 9: baynews9.com/fl/tampa/news/2…

Hope begins with research—and becomes real through patients. 💙 Heather Curley is living beyond expectations after enrolling in a pioneering dendritic cell vaccine clinical trial for leptomeningeal disease at @MoffittNews. Her story is a powerful reminder of why we never stop pushing for better treatments. Read her inspiring journey: Bay News 9: baynews9.com/fl/tampa/news/2… #Glioblastoma #BrainCancer #LeptomeningealDisease #CancerResearch #Immunotherapy #ClinicalTrials #MoffittCancerCenter

It was a pleasure to host Dr. Isabella Glitza, MD, PhD, from MD Anderson Cancer Center last week! We shared ideas about collaborating to improve care for our patients. She is a expert on Melanoma LMD and gave a fantastic talk. We have lots of other to work together on including trial and sharing reagents! Very exciting! We also had a wonderful dinner with Dr. Glitza in a great restaurant. Great time, great food and great friends Photos: Dr. Golnaz Morad and Dr. Glitza, Members of the Department of Neuro-Oncology with Dr. Glitza (center, black attire), followed by a wonderful dinner with colleagues. Clockwise from the lower left corner 8pm: Inna Smalley, PhD, Dr. Isabella "Bella" Glitza, Dr. Jose Guevara, PhD, Dr. Peter Forsyth, and Dr. Yolanda Piña.@MoffittNews #NeuroOncology #Melanoma #LMD #CancerResearch #Collaboration

It was a pleasure to host Dr. Isabella Glitza, MD, PhD, from MD Anderson Cancer Center last week! We shared ideas about collaborating to improve care for our patients. She is a expert on Melanoma LMD and gave a fantastic talk. We have lots of other to work together on including trial and sharing reagents! Very exciting! We also had a wonderful dinner with Dr. Glitza in a great restaurant. Great time, great food and great friends Photos: Members of the Department of Neuro-Oncology with Dr. Glitza (center, black attire), followed by a wonderful dinner with colleagues. Clockwise from the lower left corner 8pm: Inna Smalley, PhD, Dr. Isabella "Bella" Glitza, Dr. Jose Guevara, PhD, Dr. Peter Forsyth, and Dr. Yolanda Piña. @MoffittNews #NeuroOncology #Melanoma #LMD #CancerResearch #Collaboration